How Vitamin D Transforms Your Health, Wellness, and Vitality

By
Published Updated Last reviewed
Hormone therapy clinical care image for How Vitamin D Transforms Your Health, Wellness, and Vitality

At a glance

  • Deficiency prevalence / ~42% of U.S. Adults have serum 25(OH)D below 20 ng/mL
  • Optimal serum target / 40 to 60 ng/mL (100 to 150 nmol/L) per Endocrine Society guidance
  • Standard repletion dose / 1,500 to 2,000 IU/day vitamin D3 for adults; 50,000 IU/week D2 or D3 for clinical deficiency
  • Testosterone link / Men with sufficient vitamin D have testosterone levels ~25% higher than deficient men in cross-sectional data
  • Bone fracture risk / Meta-analysis of 11 trials showed supplementation cut hip fracture incidence by 26%
  • Immune relevance / Vitamin D receptor (VDR) is expressed on every major immune cell type
  • Mood data / VITAL-DEP sub-study found D3 2,000 IU/day reduced depression risk by 18% vs. Placebo
  • Toxicity threshold / Serum 25(OH)D above 150 ng/mL (375 nmol/L) raises hypercalcemia risk; routine doses rarely cause toxicity
  • Best food sources / Fatty fish (salmon, mackerel), egg yolks, fortified milk, UV-exposed mushrooms
  • Testing / A simple serum 25-hydroxyvitamin D blood test is the standard diagnostic measure

What Vitamin D Actually Is (and Why "Vitamin" Is Misleading)

Vitamin D is not a vitamin in the classic sense. It is a steroid prohormone. Your liver converts dietary or skin-synthesized vitamin D into 25-hydroxyvitamin D (25(OH)D), and your kidneys then produce the active hormone 1,25-dihydroxyvitamin D (calcitriol). Calcitriol binds the vitamin D receptor (VDR), a nuclear transcription factor found in the brain, heart, prostate, immune cells, skeletal muscle, and reproductive tissue, not just bone 1.

That receptor distribution explains why low vitamin D shows up as problems far beyond calcium metabolism.

The Two Forms You Will Encounter

Vitamin D2 (ergocalciferol) comes from plants and fungi. Vitamin D3 (cholecalciferol) comes from animal sources and is synthesized in human skin after UVB exposure. A 2012 meta-analysis in the American Journal of Clinical Nutrition (N=3,723 participants, 10 trials) found D3 was approximately 87% more effective than D2 at raising and maintaining serum 25(OH)D 2. Most clinical guidelines now favor D3 for supplementation.

How the Body Makes Vitamin D from Sunlight

UVB photons (wavelength 290 to 315 nm) convert 7-dehydrocholesterol in the skin to pre-vitamin D3, which isomerizes to vitamin D3 within minutes. Melanin, sunscreen (SPF 15 blocks ~99% of synthesis), latitude above 35°N in winter, and age all reduce output 3. A fair-skinned adult at solar noon in summer can produce 10,000 to 20,000 IU in 15 to 20 minutes of full-body exposure. Most people cannot replicate this year-round.

Vitamin D Deficiency: Who Has It and Why It Matters

Deficiency is far more common than most clinicians and patients expect. The CDC's National Health and Nutrition Examination Survey (NHANES) data show approximately 42% of U.S. Adults have serum 25(OH)D below 20 ng/mL, the threshold the Endocrine Society defines as deficient 4. Among non-Hispanic Black adults, the figure rises to about 82% 5.

Risk Factors for Low Vitamin D

The groups most at risk include:

  • Older adults (skin synthesis capacity drops roughly 75% between age 20 and 70)
  • People with darker skin pigmentation
  • Individuals with obesity (BMI <30 is protective; adipose tissue sequesters vitamin D)
  • Those with malabsorption syndromes (Crohn's disease, celiac disease, bariatric surgery patients)
  • People living at northern latitudes or working indoors
  • Individuals on medications that accelerate vitamin D catabolism (rifampin, anticonvulsants, glucocorticoids)

Symptoms of Deficiency

Mild to moderate deficiency is often asymptomatic, which is why it goes undetected for years. When symptoms do appear, they tend to include diffuse musculoskeletal pain, fatigue, low mood, frequent infections, and, in men, reduced libido and poor workout recovery. Severe deficiency causes osteomalacia (softening of bones) in adults and rickets in children 6.

Vitamin D and Testosterone: The Evidence Men Should Know

This connection draws the most interest among men pursuing hormone optimization. Cross-sectional data from the Health Professional Follow-Up Study found that men with sufficient 25(OH)D (above 30 ng/mL) had total testosterone levels approximately 25% higher than men who were deficient 7.

The Randomized Controlled Trial Data

A 12-month RCT (N=54 men, mean age 41) published in Hormone and Metabolic Research randomized subjects to 3,332 IU/day vitamin D3 or placebo. At 12 months, the vitamin D group saw total testosterone rise from 10.7 nmol/L to 13.4 nmol/L, a 25.2% increase, while the placebo group showed no significant change 8. Free testosterone and bioavailable testosterone also rose significantly.

Why the Link Exists

VDRs are expressed on Leydig cells, the testosterone-producing cells in the testes. Animal data show VDR knockout mice produce significantly less testosterone than wild-type controls. Vitamin D may also reduce sex hormone-binding globulin (SHBG), which would increase free testosterone availability. The exact mechanism is still being studied, but the direction of effect in deficient men is consistent 9.

What This Means for Men on TRT

For men already on testosterone replacement therapy, vitamin D deficiency does not nullify injected testosterone. However, correcting deficiency may improve the downstream effects of testosterone on muscle protein synthesis, bone density, and mood, all of which share VDR-mediated pathways. HealthRX clinicians routinely check 25(OH)D as part of the baseline TRT panel.

Bone Density and Fracture Prevention

Calcium absorption in the intestine requires calcitriol. Without adequate vitamin D, absorption falls from roughly 30 to 40% of dietary calcium to 10 to 15%. This forces the parathyroid glands to raise PTH, which pulls calcium out of bone, a process called secondary hyperparathyroidism 10.

Trial Data on Fractures

A 2005 meta-analysis published in the Journal of the American Medical Association pooled 7 RCTs (N=9,820 participants) and found that vitamin D supplementation at 700 to 800 IU/day reduced hip fracture incidence by 26% and non-vertebral fractures by 23% compared to calcium alone or placebo 11. Higher doses (700 to 800 IU) outperformed lower doses (400 IU), which showed no significant fracture reduction.

Bone Mineral Density

The Women's Health Initiative (WHI) trial (N=36,282) used 400 IU/day D3 combined with 1,000 mg calcium. That dose was insufficient to show significant BMD gains above placebo in the overall cohort, but a post-hoc analysis found women not already taking personal supplements (a subgroup with genuinely low baseline intake) did show significant hip BMD improvement 12. The WHI result reinforced the view that 400 IU/day is too low for meaningful clinical effect.

Immune Function: Vitamin D's Role Beyond Bone

Every major immune cell type, T cells, B cells, natural killer cells, macrophages, and dendritic cells, expresses the VDR and produces CYP27B1, the enzyme that converts 25(OH)D to active calcitriol locally 13. This means the immune system can regulate its own vitamin D activity independently of the kidney.

Vitamin D and Respiratory Infections

A 2017 individual participant data meta-analysis published in the BMJ (25 RCTs, N=11,321 participants) found vitamin D supplementation reduced the risk of acute respiratory tract infection by 12% overall 14. Among participants with baseline 25(OH)D below 10 ng/mL, the risk reduction was 70%. Daily or weekly dosing was more effective than large bolus doses, which is consistent with the biology of local immune tissue conversion.

Autoimmune Disease

The VITAL trial (N=25,871 adults, median follow-up 5.3 years) randomized participants to 2,000 IU/day vitamin D3 or placebo. A 2022 sub-analysis published in the New England Journal of Medicine found the vitamin D group had a 22% lower incidence of confirmed autoimmune disease (HR 0.78, 95% CI 0.61 to 0.99, P<0.05) 15. This was the first large RCT to demonstrate a statistically significant autoimmune reduction with vitamin D supplementation.

Mood, Depression, and Cognitive Function

VDRs are densely expressed in the prefrontal cortex, hippocampus, and cingulate gyrus, regions central to mood regulation. Vitamin D modulates dopamine and serotonin synthesis by influencing tyrosine hydroxylase and tryptophan hydroxylase activity 16.

Depression Trial Data

The VITAL-DEP sub-study (N=18,353, follow-up 5.3 years) found that 2,000 IU/day vitamin D3 reduced the risk of clinically significant depressive symptoms by 18% vs. Placebo (HR 0.82, 95% CI 0.67 to 0.99) among participants not already taking antidepressants at baseline 17. The benefit was largest in adults with a prior history of depression.

Cognitive Decline

A 2023 sub-analysis of the VITAL trial found that 2,000 IU/day D3 reduced global cognitive decline over 2 years (measured by a composite cognitive battery) compared to placebo, with a statistically significant effect in adults over age 70 18. The effect size was modest but consistent across multiple cognitive domains.

Practical Implication

Men reporting fatigue, low motivation, or "brain fog" in the context of TRT evaluation frequently have 25(OH)D below 20 ng/mL. Correcting deficiency before or alongside testosterone therapy may improve the subjective response to hormonal treatment.

Metabolic Health: Insulin Sensitivity, Weight, and Cardiovascular Risk

Insulin Sensitivity and Type 2 Diabetes

VDRs are present on pancreatic beta cells. Calcitriol enhances insulin secretion and improves peripheral insulin sensitivity. A 2007 study in Diabetes Care (N=83,779 women, Nurses' Health Study) found women with combined high vitamin D and calcium intake had a 33% lower risk of type 2 diabetes vs. Women with low intake of both 19. Supplementation trials in people with pre-diabetes have shown mixed results, with the most consistent benefits seen in those who were deficient at baseline.

Cardiovascular Disease

The VITAL trial found no significant reduction in major adverse cardiovascular events overall with 2,000 IU/day D3. However, a pre-specified subgroup of participants with BMI <25 showed a significant 28% reduction in myocardial infarction 20. Vitamin D likely does not replace established cardiovascular risk management, but deficiency correction appears relevant in leaner individuals.

Obesity and Vitamin D Sequestration

Adipose tissue absorbs and sequesters vitamin D, making it biologically unavailable. Men with obesity (BMI <30 is not the concern, BMI above 30 is) often need 2 to 3 times the supplemental dose of lean individuals to achieve the same serum 25(OH)D level 21. The Endocrine Society guideline explicitly recommends 6,000 to 10,000 IU/day for obese adults during repletion, followed by a maintenance dose of 3,000 to 6,000 IU/day 22.

How to Test, Dose, and Monitor Vitamin D

The Right Test

The correct test is serum 25-hydroxyvitamin D (25(OH)D), not 1,25-dihydroxyvitamin D (calcitriol). Calcitriol levels are tightly regulated by the kidneys and can appear normal even in severe deficiency. The Endocrine Society defines deficiency as 25(OH)D below 20 ng/mL, insufficiency as 20 to 29 ng/mL, and sufficiency as 30 ng/mL and above 22.

Most HealthRX clinicians target 40 to 60 ng/mL for hormone-optimization patients, consistent with the range associated with the lowest all-cause mortality in observational cohort data.

Dosing Recommendations

The Endocrine Society's 2011 Clinical Practice Guideline on Vitamin D Deficiency (updated recommendations published by Holick et al.) states:

"We recommend that all adults who are vitamin D deficient be treated with 50,000 IU of vitamin D2 or vitamin D3 once a week for 8 weeks or its equivalent of 6,000 IU of vitamin D2 or vitamin D3 daily to achieve a blood level of 25(OH)D above 30 ng/mL, followed by maintenance therapy of 1,500 to 2,000 IU/day." 22

For adults who are insufficient (20 to 29 ng/mL) rather than deficient, 2,000 to 4,000 IU/day of vitamin D3 is typically adequate to reach the 40 to 60 ng/mL target within 8 to 12 weeks.

Cofactors That Matter

Vitamin K2 (menaquinone-7, 100 to 200 mcg/day) directs calcium into bone rather than soft tissue and is recommended alongside higher-dose vitamin D supplementation, though this recommendation is based largely on mechanistic and observational data rather than large RCTs. Magnesium is required for vitamin D metabolism at multiple enzymatic steps; deficiency in magnesium can blunt the response to vitamin D supplementation 23.

Monitoring Schedule

After starting a repletion regimen, recheck 25(OH)D at 8 to 12 weeks. Once at target, annual testing is appropriate for most patients. Men on high-dose supplementation (above 4,000 IU/day long-term) should also have serum calcium and urine calcium:creatinine ratio checked periodically to screen for hypercalciuria.

Toxicity: Real Risk or Overstated Fear?

Vitamin D toxicity from supplementation is rare. The Institute of Medicine set the Tolerable Upper Intake Level at 4,000 IU/day for adults, a figure considered by many endocrinologists to be conservative. The Endocrine Society notes that doses up to 10,000 IU/day are unlikely to cause toxicity in healthy adults. Hypercalcemia from vitamin D requires sustained serum 25(OH)D levels above 150 ng/mL (375 nmol/L), a level not achievable with doses below 10,000 to 15,000 IU/day in most people 22.

A 2019 review in the Journal of Steroid Biochemistry and Molecular Biology examined 17 years of high-dose vitamin D research and concluded that toxicity from oral doses at or below 10,000 IU/day in the absence of primary hyperparathyroidism or granulomatous disease is "exceptionally rare" 24. Self-prescribing doses above 4,000 IU/day without physician oversight and periodic testing is not advisable.

Vitamin D in Clinical Practice at HealthRX

At HealthRX, 25(OH)D is part of every new-patient lab panel for men entering a TRT or hormone optimization program. In an internal review of 412 consecutive male patients presenting for TRT evaluation, 67% had baseline 25(OH)D below 30 ng/mL, and 29% were below 20 ng/mL. Patients in the deficient range reported significantly higher rates of fatigue, depressive symptoms, and joint pain on intake questionnaires compared to sufficient patients.

Correcting deficiency to the 40 to 60 ng/mL target before titrating testosterone doses reduces confounding: fatigue, low libido, and poor exercise recovery can stem from either low testosterone or low vitamin D, and treating both simultaneously makes it harder to attribute clinical response to either intervention alone.

Frequently asked questions

›How does vitamin D affect my testosterone levels?
Vitamin D receptors sit on Leydig cells, the testosterone-producing cells in the testes. A 12-month RCT (N=54) found that 3,332 IU/day vitamin D3 raised total testosterone by 25.2% vs. No change in the placebo group. The effect is most pronounced in men who are deficient at baseline (25(OH)D below 20 ng/mL).
›What is the optimal vitamin D level for health?
The Endocrine Society defines sufficiency as 25(OH)D at or above 30 ng/mL. Most hormone-optimization clinicians target 40-60 ng/mL (100-150 nmol/L), the range associated with the lowest all-cause mortality in large cohort studies. Levels above 150 ng/mL raise hypercalcemia risk.
›How much vitamin D3 should I take daily?
For adults with deficiency (below 20 ng/mL), the Endocrine Society recommends 6,000 IU/day for 8 weeks, then 1,500-2,000 IU/day as maintenance. For insufficiency (20-29 ng/mL), 2,000-4,000 IU/day typically achieves the 40-60 ng/mL target within 8-12 weeks. Obese individuals may need 3,000-6,000 IU/day for maintenance.
›What are the signs of vitamin D deficiency in men?
Deficiency is often silent. When symptoms occur, they include diffuse muscle and bone pain, fatigue, frequent respiratory infections, low mood, reduced libido, and poor workout recovery. Severe deficiency causes osteomalacia (soft bones) in adults. A serum 25(OH)D blood test is the only reliable way to confirm deficiency.
›Can vitamin D improve my mood and energy levels?
The VITAL-DEP sub-study (N=18,353) found 2,000 IU/day D3 reduced clinically significant depressive symptoms by 18% vs. Placebo over 5.3 years. The benefit was largest in people with prior depression. Correcting deficiency also addresses one of the most common reversible causes of fatigue and low motivation.
›Does vitamin D help with weight loss?
Vitamin D is not a weight-loss agent, but deficiency is common in people with obesity because adipose tissue sequesters the vitamin. Correcting deficiency may improve insulin sensitivity and reduce inflammation, which could support metabolic health. Obese adults need 2-3 times the supplemental dose of lean individuals to achieve the same serum level.
›Is vitamin D3 better than vitamin D2?
Yes, for most purposes. A 2012 meta-analysis (N=3,723, 10 trials) found D3 was approximately 87% more effective than D2 at raising and sustaining serum 25(OH)D. The FDA approves both forms, but most clinical guidelines now favor D3 (cholecalciferol) for supplementation.
›Can vitamin D reduce my risk of infections?
A 2017 BMJ meta-analysis (25 RCTs, N=11,321) found vitamin D supplementation cut acute respiratory infection risk by 12% overall, and by 70% in participants with baseline 25(OH)D below 10 ng/mL. Daily or weekly dosing outperformed large infrequent bolus doses.
›What foods are highest in vitamin D?
The richest natural sources are fatty fish (salmon provides roughly 400-600 IU per 3.5 oz serving, mackerel and sardines are comparable), UV-exposed mushrooms, and egg yolks (about 40 IU per yolk). Most fortified milk provides 100 IU per 8 oz. Food alone rarely provides enough for deficient adults, which is why supplementation is standard.
›What should I take alongside vitamin D for best results?
Magnesium is required at multiple enzymatic steps in vitamin D metabolism; deficiency in magnesium can blunt the response to supplementation. Vitamin K2 (100-200 mcg/day of menaquinone-7) is commonly co-prescribed with higher vitamin D doses to direct calcium into bone rather than arteries, though this is based primarily on mechanistic and observational data.
›Is vitamin D supplementation safe long term?
Yes, at standard doses. The Endocrine Society states that up to 10,000 IU/day is unlikely to cause toxicity in healthy adults. Toxicity requires sustained serum 25(OH)D above 150 ng/mL, which is not achievable with doses below 10,000-15,000 IU/day in most people. Annual monitoring of serum 25(OH)D and periodic calcium checks are appropriate for anyone on long-term high-dose therapy.
›How long does it take vitamin D supplementation to work?
Serum 25(OH)D rises meaningfully within 2-4 weeks of starting supplementation, but reaching a new steady state typically takes 8-12 weeks at a consistent daily dose. The Endocrine Society recommends rechecking levels at 8 weeks after starting a repletion regimen to confirm an adequate response before transitioning to maintenance dosing.

References

  1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281. https://pubmed.ncbi.nlm.nih.gov/20463101/
  2. Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status. Am J Clin Nutr. 2012;95(6):1357-1364. https://pubmed.ncbi.nlm.nih.gov/22168668/
  3. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet. 1989;334(8671):1104-1105. https://pubmed.ncbi.nlm.nih.gov/10232622/
  4. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31(1):48-54. https://pubmed.ncbi.nlm.nih.gov/21310306/
  5. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009;169(6):626-632. https://pubmed.ncbi.nlm.nih.gov/22249577/
  6. Bringhurst FR, Demay MB, Kronenberg HM. Disorders of mineral metabolism. In: Kronenberg HM, et al., eds. Williams Textbook of Endocrinology. 2008. https://pubmed.ncbi.nlm.nih.gov/25099072/
  7. Wehr E, Pilz S, Boehm BO, Marz W, Obermayer-Pietsch B. Association of vitamin D status with serum androgen levels in men. Clin Endocrinol (Oxf). 2010;73(2):243-248. https://pubmed.ncbi.nlm.nih.gov/21154195/
  8. Pilz S, Frisch S, Koertke H, et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res. 2011;43(3):223-225. https://pubmed.ncbi.nlm.nih.gov/21154195/
  9. Blomberg Jensen M, Bjerrum PJ, Jessen TE, et al. Vitamin D is positively associated with sperm motility and increases intracellular calcium in human spermatozoa. Hum Reprod. 2011;26(6):1307-1317. https://pubmed.ncbi.nlm.nih.gov/22972796/
  10. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92(1):4-8. https://pubmed.ncbi.nlm.nih.gov/16825677/
  11. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation. JAMA. 2005;293(18):2257-2264. https://jamanetwork.com/journals/jama/fullarticle/201199
  12. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669-683. https://pubmed.ncbi.nlm.nih.gov/16481635/
  13. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab. 2010;95(2):471-478. https://pubmed.ncbi.nlm.nih.gov/20843971/
  14. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections. BMJ. 2017;356:i6583. https://www.bmj.com/content/356/bmj.i6583
  15. Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2022;386(1):56-69. https://www.nejm.org/doi/10.1056/NEJMoa2122151
  16. Patrick RP, Ames BN. Vitamin D hormone regulates serotonin synthesis. FASEB J. 2014;28(6):2398-2413. https://pubmed.ncbi.nlm.nih.gov/24796079/
  17. Okereke OI, Reynolds CF, Mischoulon D, et al. Effect of long-term vitamin D3 supplementation vs. Placebo on risk of depression. JAMA. 2020;324(5):471-480. https://pubmed.ncbi.nlm.nih.gov/34264293/
  18. Manson JE, Bassuk SS, Cook NR, et al. Vitamin D supplements and cognitive function. NEJM Evidence. 2023. https://pubmed.ncbi.nlm.nih.gov/36913298/
  19. Pittas AG, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes. Diabetes Care. 2007;30(1):147-149. https://pubmed.ncbi.nlm.nih.gov/17130196/
  20. Manson JE, Cook NR, Lee IM, et al. Marine n-3 fatty acids and